News Outlets Discuss Various Aspects Of COVID-19 Vaccine R&D, Availability, Licensing; Antibody Drug Access; Operation Warp Speed Leadership; Drug Shortages

CNBC: ‘Learn to live with the pandemic’: Physicians warn that a vaccine may not prevent Covid from becoming endemic (Meredith, 10/22).

The Hill: Azar says COVID-19 vaccine could be delivered to vulnerable people by January (Axelrod, 10/22).

NPR: How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated? (Harris, 10/21).

STAT: Blood plasma showed no benefit in Covid-19 patients in trial — a finding that could re-energize debate (Garde/Herper, 10/22).

STAT: ‘A matter of life and death’: Why a Brazilian lawmaker wants compulsory licensing for Covid-19 products (Silverman, 10/22).

STAT: Democrats want to fire Warp Speed’s Moncef Slaoui and overhaul the program. But if Biden wins, should he? (Florko, 10/22).

STAT: As Covid-19 intensifies, shortages of staple drugs may grow worse (Silverman, 10/21).

Washington Post: Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities (Johnson, 10/22).

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.